Secondary t(9;22)(q34;q11.2)/BCR-ABL1 Rearrangement Is a Fatal Event in Myeloid/Lymphoid Neoplasms

被引：0
|
作者：
Zheng, Lan [1 ]
Han, Xin [1 ]
Gong, Zimu [1 ]
Medeiros, L. Jeffrey [1 ]
Hu, Shimin [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
LABORATORY INVESTIGATION | 2017年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1556
引用
收藏
页码：388A / 388A
页数：1
相关论文
共 50 条
  • [31] Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study
    Gondran, Camille
    Dumas, Pierre-Yves
    Berard, Emilie
    Bidet, Audrey
    Delabesse, Eric
    Tavitian, Suzanne
    Leguay, Thibaut
    Huguet, Francoise
    Borel, Cecile
    Forcade, Edouard
    Vergez, Francois
    Vial, Jean-Philippe
    Rieu, Jean Baptiste
    Lechevalier, Nicolas
    Luquet, Isabelle
    Canali, Alban
    Klein, Emilie
    Sarry, Audrey
    de Grande, Anne-Charlotte
    Pigneux, Arnaud
    Recher, Christian
    Largeaud, Laetitia
    Bertoli, Sarah
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [32] Translocation (6;9;22)(p25;q34;q11.2) identified by FISH in acute leukemia
    Gonzalez, GJR
    Notohamiprodjo, M
    CANCER GENETICS AND CYTOGENETICS, 1996, 92 (01) : 82 - 84
  • [33] Three-way Philadelphia translocation t(9;10;22)(q34;p11.2;q11.2) as a secondary abnormality in an imatinib mesylate-resistant chronic myeloid leukemia patient
    Al-Achkar, Walid
    Wafa, Abdulsamad
    Ikhtiar, Adnan
    Liehr, Thomas
    ONCOLOGY LETTERS, 2013, 5 (05) : 1656 - 1658
  • [34] A case of chronic myelogenous leukemia in pregnancy characterized by a complex translocation t(9; 22; 11)( q34; q11.2; q13)
    Kumar, Surachit
    Apostolova, Mariya
    Woolley, Paul V.
    HEMATOLOGY REPORTS, 2011, 3 (03) : 86 - 90
  • [35] A complex translocation (9;22;16)(q34;q11.2;p13) in chronic myelocytic leukemia
    Espinoza, JPM
    Cárdenas, VJP
    Jiménez, EAV
    Angulo, MG
    Flores, MAE
    García, JRG
    CANCER GENETICS AND CYTOGENETICS, 2005, 157 (02) : 175 - 177
  • [36] JAK2 V617F mutation positive primary myelofibrosis with concomitant t(9;11;22)(q34;p15;q11.2) but no BCR/ABL fusion
    Au, Wing-Yan
    Wan, Thomas S. K.
    Ma, Edmond S. K.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (03) : 435 - 437
  • [37] JAK2 V617F mutation positive primary myelofibrosis with concomitant t(9;11;22)(q34;p15;q11.2) but no BCR/ABL fusion
    Wing-Yan Au
    Thomas S. K. Wan
    Edmond S. K. Ma
    International Journal of Hematology, 2013, 97 : 435 - 437
  • [38] Isolated myelosarcoma development in an adolescent chronic myeloid leukemia patient with t(9;22)(q34;q11.2),+8,+14,+21, and der(1)(p36)
    Oeren, Hale
    Yilmaz, Sebnem
    Sercan, Zeynep
    Demircioglu, Fatih
    Yueksel, Erdinc
    Irken, Guelersu
    CANCER GENETICS AND CYTOGENETICS, 2008, 182 (01) : 43 - 45
  • [39] Cryptic t(9;22)(q34;q11.2) is not detected in acute lymphoblastic leukemia (ALL) patients with gain of a chromosome 8 (+8).
    Olney, HJ
    Larson, RA
    Le Beau, MM
    BLOOD, 2001, 98 (11) : 109A - 109A
  • [40] A case of therapy-related acute lymphoblastic leukemia with t(9;22)(q34;q11.2) following treatment of breast cancer
    Tazi, I.
    Nafil, H.
    Mahmal, L.
    Elomrani, A.
    Khouchani, M.
    Tahri, A.
    Hda, N.
    LEUKEMIA RESEARCH, 2011, 35 (05) : E58 - E58
12345